UPDATE : Monday, December 10, 2018
SillaJen to develop biomarker for JX-970
SillaJen is rolling up its sleeves to develop a biomarker for an investigat...
by So Jae-hyeon  |  2018-07-03 14:19
Ministry approves CJ Healthcare’s CINV treatment
CJ Healthcare said Monday it has received approval from the Ministry of Foo...
by Lee Han-soo  |  2018-07-03 12:47
Alexion Pharma Korea’s aHUS therapy Soliris gains coverage
Alexion Pharma Korea gained reimbursement from the Ministry of Health and W...
by Marian Chu  |  2018-07-02 17:02
Takeda’s diabetes therapy to see 10 generics soon
Ten generics of Takeda Pharmaceutical’s diabetes adjunct therapy Actos met ...
by Marian Chu  |  2018-07-02 17:01
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’
Eliquis (ingredient: apixaban) by Bristol-Myers Squibb Korea and Korea Pfiz...
by Nam Doo-hyun  |  2018-07-02 16:47
SK Bioscience starts business
SK Bioscience CEO Ahn Jae-yong SK Chemicals announced on Sunday that it h...
by Lee Han-soo  |  2018-07-02 15:00
Sanofi Korea presents findings on head-to-head trial on Toujeo vs. Tresiba
Sanofi presented head-to-head trial results for Toujeo Monday. Sanofi’s d...
by Marian Chu  |  2018-06-29 18:01
VUNO unveils SW with excellent function for predicting cardiac arrest
VUNO has released new study results, which show its artificial intelligence...
by Marian Chu  |  2018-06-29 17:29
Eisai’s Aricept dominates dementia treatment market
Eisai’s Aricept has comfortably secured the No. 1 place in the local dement...
by So Jae-hyeon  |  2018-06-29 15:24
BMS Korea wins fight for Eliquis patent
Bristol-Myers Squibb (BMS) Korea said it has won a suit against domestic dr...
by Nam Doo-hyun  |  2018-06-29 14:41
Botulinum toxin makers compete to expand indications
Local developers of botulinum toxins are increasingly competing to expand t...
by So Jae-hyeon  |  2018-06-29 14:07
Korean pharmaceuticals fail to invalidate Invokana patent
A three-year-long trial to invalidate the patent for Janssen’s diabetes dru...
by Marian Chu  |  2018-06-28 17:58
Pfizer’s kidney cancer therapy Inlyta to be reimbursed in July
The Ministry of Health and Welfare announced Wednesday that it would add Pf...
by Lee Hye-seon  |  2018-06-28 17:57
Weight-loss drug Saxenda creates marketing sensation in Korea
Saxenda (ingredient: liraglutide), an injectable drug to treat obesity, is ...
by Lee Hye-seon  |  2018-06-28 16:40
Hugel, Hamni to cooperate in urology market
Hugel, a biopharmaceutical company, announced Thursday that it has entered ...
by Lee Han-soo  |  2018-06-28 16:39
Herbalife Korea publishes results of genetic big data analysis
Herbalife Korea announced Thursday the results of its big data analysis of ...
by Marian Chu  |  2018-06-28 14:52
Hepatitis B reactivation added to Simulect precautions
The government said it has ordered Novartis to add “hepatitis B reactivatio...
by Lee Hye-seon  |  2018-06-28 12:20
Will Celebrex shake off tainted image?
A Korean expert supported the U.S. Food and Drug Administration’s decision ...
by Marian Chu  |  2018-06-27 16:24
Boryung, EDGC’s service to predict genetic risks for soon-to-be moms
Boryung Biopharma and Eone Diagnomics Genome Center (EDGC) have launched a ...
by Marian Chu  |  2018-06-27 15:31
GC Lab Cell secures tech for Natural Killer cell-based immunotherapy
GC Lab Cell is making headway with developing its Natural Killer (NK) cell-...
by Marian Chu  |  2018-06-27 14:19
Back to Top